June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Oxytocin and Secretin Receptors on the Ocular Surface
Author Affiliations & Notes
  • Jacqueline Breanna Lopez
    Ophthalmology, University of California San Francisco, San Francisco, California, United States
  • Yien Ming Kuo
    Ophthalmology, University of California San Francisco, San Francisco, California, United States
  • Matilda F Chan
    Ophthalmology, University of California San Francisco, San Francisco, California, United States
  • Finn Wolfreys
    Ophthalmology, University of California San Francisco, San Francisco, California, United States
  • Bryan Winn
    Ophthalmology, University of California San Francisco, San Francisco, California, United States
  • Footnotes
    Commercial Relationships   Jacqueline Lopez None; Yien Ming Kuo None; Matilda Chan Surrozen Operating Inc., Code C (Consultant/Contractor); Finn Wolfreys None; Bryan Winn Provisional Patent for use of topical oxytocin and secretin to treat ocular surface inflammation, Code P (Patent)
  • Footnotes
    Support  This work was made possible by the UCSF Vision Core Grant P30 EY002162 and Research to Prevent Blindness Unrestricted Grant to the UCSF Department of Ophthalmology, NIH/NEI R01 EY032161, and All May See Foundation Grant.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3156. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jacqueline Breanna Lopez, Yien Ming Kuo, Matilda F Chan, Finn Wolfreys, Bryan Winn; Oxytocin and Secretin Receptors on the Ocular Surface. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3156.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Oxytocin (OXTR) and secretin receptors (SCTR) have demonstrated anti-inflammatory and anti-nociceptive roles in various tissues. The purpose of this study is to determine the presence of OXTR and SCTR within ocular tissues, to establish a basis for anti-inflammatory and anti-nociceptive roles on the ocular surface.

Methods : Immunofluorescence imaging: Human cornea from discarded transplant (DMEK, DSAEK) materials were divided into central (no endothelial layer) and peripheral (cornea, conjunctiva/sclera) regions. Mouse ocular tissues were obtained from wild type C57BL/6J mice. Tissue sections were stained with anti-OXTR or anti-SCTR primary antibody and Alexa Fluor 488 secondary antibody. Images were taken on a Zeiss LSM900 Airyscan confocal microscope.

Gene expression analysis: Human cornea (4 peripheral, 3 central), tarsus (3), and caruncle (1) were obtained from discarded surgical tissues. Mouse cornea, conjunctiva, tarsus, retina, and control (skin, muscle) tissues were extracted from 2 male and 2 female wild type C57BL/6J mice. RNA was extracted and converted to cDNA for qPCR with primers for human and mouse Oxtr, Sctr, and control genes (Hprt, Tbp). Relative RNA expression for Oxtr and Sctr in experimental tissues compared to control tissues (known to have low amounts of Oxtr / Sctr expression) was determined using Livak analysis.

Results : Immunofluorescence imaging shows OXTR and SCTR expression on the epithelial surface of central and peripheral human cornea and OXTR expression in mouse meibomian glands. In humans, there was higher Oxtr RNA expression in peripheral cornea (62.1x), tarsus (12.1x), caruncle (5.7x), and central cornea (4.9x) and higher Sctr RNA expression in tarsus (12.2x), peripheral cornea (8.9x), caruncle (3.3x), and central cornea (1.5x), compared to muscle control tissue. In female mice, Oxtr RNA showed highest expression in conjunctiva (18.6x) followed by retina (14.6x), cornea (7.5x), and tarsus (4.6x) compared to muscle control tissue. In male mice, Oxtr RNA showed highest expression in retina (14.6x), cornea (11.6x), tarsus (6.7x), and conjunctiva (5.50x) compared to muscle tissue. There was low expression of Sctr RNA in male and female mice ocular tissues.

Conclusions : OXTR and SCTR are expressed on both the human and mouse ocular surface, with high levels of OXTR in conjunctiva. This warrants further investigation of the role that OXTR and SCTR may have in ocular inflammatory and pain pathways.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×